Book

Breast cancer remains one of the greatest challenges in modern oncology, with rising incidence and persistent barriers to effective treatment. While conventional therapies have improved survival, resistance, relapse, and side effects highlight the urgent need for alternative strategies. Among the most promising frontiers is mycochemistry—the study of fungal-derived bioactive compounds—offering unique structural diversity and powerful anticancer properties.   Mycochemical Approaches to Breast Cancer: Exploring Fungal-Derived Bioactive Compounds from Molecular Mechanisms to Preclinical and Therapeutic Applications provides the first comprehensive exploration of fungi as novel allies in breast cancer therapy. Drawing on insights from oncology, natural product chemistry, molecular biology, and nanotechnology, this book uncovers how fungal metabolites regulate apoptosis, suppress metastasis, modulate immunity, and even reshape epigenetic landscapes in cancer cells.   The volume moves from foundational science to translational opportunities, covering compound isolation, mechanistic studies, preclinical validation, pharmacokinetics, and advanced delivery systems. Special emphasis is placed on nanotechnology-enabled fungal therapeutics and the potential for personalized, mycochemical-based oncology in the future.   Richly detailed yet accessible, this book is an invaluable reference for oncologists, pharmacologists, mycologists, cancer researchers, and industry professionals seeking innovative drug discovery strategies. It not only charts the scientific progress of fungal metabolites in breast cancer but also envisions their integration into precision medicine.